Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 868-877

  Beekman, Marjolein ^b   Ungard, Jesse T ^a   Gasior, Maciej ^a,d,e   Carter, Richard B ^c   Dijkstra, Durk ^b   Goldberg, Steven R ^a   Witkin, Jeffrey M ^a,f  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Department of Medicinal Chemistry   (Netherlands)

^c Department of Pharmacokinetics and Drug Metabolism   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^f NIDA Addiction Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLONAZEPAM; CONVULSANT AGENT; DIAZEPAM; ETHOSUXIMIDE; GANAXOLONE; PENTETRAZOLE; PHENOBARBITAL; STEROID; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REARING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; PREGNANOLONE; RECEPTORS, GABA-A;

EID: 0031888527     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ator NA, Grant KA, Purdy RH, Paul SM and Griffiths RR (1993) Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur J Pharmacol 241: 237-243.
2. Barker JL, Harrison NL, Lange GD and Owen DG (1987) Potentiation of γ-aminobutyric-acid-activated chloride conductance by a steroid anaesthetic in cultured rat spinal neurones. J Physiol 386:485-501.
3. Belelli D, Bolger MB and Gee KW (1989) Anticonvulsant profile of the progesterone metabolite 5-pregnan-3-ol-20-one. Eur J Pharmacol 166:325-329.
4. Britton KT, Page M, Baldwin H and Koob GF (1991) Anxiolytic activity of steroid anesthetic alphaxalone. J Pharmacol Exp Ther 258:124-129.
5. A receptor. J Pharmacol Exp Ther 280:1284-1295.
6. A receptor of mouse spinal neurones in culture. J Physiol 382: 132P.
7. A receptor activity by alphaxalone. Br J Pharmacol 90:491-500.
8. Crawley JN, Glowa JR, Majewska MD and Paul SM (1986) Anxiolytic activity of an endogenous adrenal steroid. Brain Res 398:382-385.
9. Deutsch SI and Mastropaolo J (1993) Discriminative stimulus properties of midazolam are shared by a GABA-receptor positive steroid. Pharmacol Biochem Behav 46:963-965.
10. Emmett-Oglesby MW, Mathis DA, Moon RTY and Lal H (1990) Animal models of drug withdrawal symptoms. Psychopharmacology 101:292-309.
11. Gasior M, Carter RB, Goldberg SR and Witkin JM (1997a) Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J Pharmacol Exp Ther 282:543-553.
12. Gasior M, Carter RB, Beekman M, Goldberg SR and Witkin JM (1997b) Neuroactive steroids as a treatment for epilepsy. Current status and future directions. Acta Neurobiologiae Experimentalis 57(suppl.):76.
13. Gee KW, Bolger MB, Brinton RE, Coirini H and McEwen BS (1988) Steroid modulation of the chloride ionophore in rat brain: Structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther 246:803-812.
14. - ionophore by steroids in rat brain. Eur J Pharmacol 136:419-423.
15. A receptor complex: The pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9:207-277.
16. Genovese RF, Elsmore TF and Witkin JM (1990) Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine. Pharmacol Biochem Behav 37:117-122.
17. Giusti P, Guidetti G, Costa E and Guidotti A (1991) The preferential antagonism of pentylenetetrazole proconflict responses differentiates a class of anxiolytic benzodiazepines with potential antipanic action. J Pharmacol Exp Ther 257:1062-1068.
18. A receptor complex. J Pharmacol Exp Ther 241:346-353.
19. Harrison NL and Simmonds MA (1984) Modulation of GABA receptor complex by a steroid anaesthetic. Brain Res 323:287-292.
20. Holtzman SG (1990) Discriminative stimulus effects of drugs: Relationship to potential for abuse. In Modern Methods in Pharmacology, Testing and Evaluation of Drugs of Abuse (vol 6), (Adler MW and Cowan A, eds) pp. 193-210. Wiley-Liss Inc., New York.
21. Kamien JB, Bickel WK, Hughes JR, Higgins ST and Smith B (1993) Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology 111:259-270.
22. Kokate TG, Svensson BE and Rogawski MA (1994) Anticonvulsant activity of neurosteroids: Correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270:1223-1229.
23. Lal H and Emmett-Oglesby MW (1983) Behavioral analogs of anxiety: Animal models. Neuropharmacology 22:1423-1441.
24. Lal H and Fielding S (1985) Antagonism of discriminative stimuli produced by anxiogenic drugs as a novel approach to bioassay of anxiolytics. Drug Dev Res 4:3-21.
25. Lal H and Sherman GT (1980) Interoceptive discriminative stimuli in the development of CNS drugs and a case of an animal model of anxiety. Ann Rep Med Chem 15:51-58.
26. Lal H, Sherman GT, Fielding S, Dunn R, Kruse and Theurer K (1980) Evidence that GABA mechanisms mediate the anxiolytic action of benzodiazepines: A study with valproic acid. Neuropharmacology 19:785-789.
27. A receptor. Trends Pharmacol Sci 8:224-227.
28. A receptor function. Trends Pharmacol Sci 16:295-303.
29. Litchfield JT and Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 95:99-113.
30. Luntz-Leybman V, Freund RK and Collins AC (1990) 5-Pregnan-3-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. Eur J Pharmacol 185:239-242.
31. MacDonald RL and Meldrum BS (1989) General principles. Principles of antiepileptic drug action. In Antiepileptic Drugs, 3rd ed, Levy R, Mattson R, Meldrum B, Penry JK and Dreifuss FE, eds) pp 59-83. New York, Raven Press, Ltd.
32. A receptor. Mechanism of action and physiological significance. Prog Neurobiol 38 379-395.
33. Majewska MD, Harrison NL, Schwartz RD, Barker JL and Paul SM (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. science 232:1004-1007.
34. Majewska MD and Schwartz RD (1987) Pregnenolone-sulfate: An endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? Brain Res 404:335-360.
35. A receptor-mediated currents via a reduction of channel opening frequency. Brain Res 489: 190-194.
36. Morrow AL, Pace JR, Purdy RH and Paul SM (1989) Characterization of steroid interactions with γ-aminobutyric acid receptor-gated chloride ion channels: Evidence for multiple steroid recognition sites. Mol Pharmacol 37:263-270.
37. Morrow AL, Suzdak PD and Paul SM (1987) Steroid hormone metabolites Potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142:483-485.
38. Morrow AL, Suzdak PD and Paul SM (1988) Benzodiazepine, barbiturate, ethanol and hypnotic steroid hormone modulation of GABA-mediated chloride ion transport in rat brain synaptoneurosomes. In Chloride Channels and Their Modulation by Neurotransmitters and Drugs, vol 45, (Biggio G and Costa E, eds) PP 247-261, Raven Press, New York.
39. - flux in brain slices as an assay for modulation by CNS depressant drugs. In Chloride Channels and Their Modulation by Neurotransmitters and Drugs, vol 45, (Biggio G and Costa E, eds) pp 247-261, Raven Press, New York.
40. Paul SM and Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322.
41. A receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 94:1257-1269.
42. Preston KL and Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2:293-313.
43. Rodin EA and Calhoun HD (1970) Metrazol tolerance in a "normal" volunteer population. J Psychiat Res 13:65-76.
44. Selye H (1941) Anesthetic effect of steroid hormones. Proc Soc Exp Biol Med 46:116-121.
45. Sherman GT and Lal H (1980) Generalization and antagonism studies with convulsant and GABAergic anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline. Neuropharmacology 19:473-479.
46. A receptor by steroids. Semin Neurosci 3:231-239.
47. Turner DM, Ransom RW, Yang JS-J and Olsen RW (1989) Steroid anesthetics and naturally occurring analogs modulate-aminobutyric acid receptor complex at a site distinct from barbiturate. J Pharmacol Exp Ther 248:960-966.
48. A receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J Physiol 456:215-245.
49. Vellucci SV and Webster RA (1984) The role of GABA in the anticonflict action of sodium valproate and chlordiazepoxide. Pharmacol Biochem Behav 21:845-851.
50. Wieland S, Belluzi JD, Stein L and Lan NC (1995) Comparative behavioral characterization of the neuroactive steroids 3α-OH,5α-pregnan-20-one and 3α-OH,5β-pregnan-20-one in rodents. Psychopharmacology 118:65-71.
51. Wu F-S, Gibbs TT and Farb DH (1990) Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol 37:597-602.